{
    "clinical_study": {
        "@rank": "79186", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases.\n\n      PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in\n      decreasing pain in patients who have bone metastases."
        }, 
        "brief_title": "Radiofrequency Ablation in Treating Patients With Bone Metastases", 
        "condition": [
            "Metastatic Cancer", 
            "Pain", 
            "Unspecified Adult Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasm Metastasis", 
                "Neoplasms", 
                "Neoplasms, Second Primary", 
                "Bone Neoplasms", 
                "Bone Marrow Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the side effects of radiofrequency ablation in patients with bone metastases.\n\n        -  Determine the effect of this regimen on pain in these patients.\n\n        -  Determine the effect of this regimen on mood in these patients.\n\n        -  Determine the effects of narcotic usage in patients treated with this regimen.\n\n        -  Determine the relationship between laboratory and imaging features of this treatment\n           and the effects of the treatment in these patients.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients undergo percutaneous CT-guided radiofrequency ablation directly to the metastatic\n      lesion over approximately 12 minutes.\n\n      Pain and mood are assessed at baseline, daily for 14 days after treatment, and at 1 and 3\n      months after treatment.\n\n      Patients are followed at 1 week and then at 1 and 3 months.\n\n      PROJECTED ACCRUAL: Approximately 75 patients will be accrued for this study within 12.5\n      months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed malignant disease with a bone lesion that\n             appears to be metastatic disease by clinical and/or imaging techniques\n\n          -  Persistent intractable pain from a solitary site of bone metastases (greater than 5\n             on pain scale of 0-10)\n\n          -  Bone metastasis must be amenable to radiofrequency ablation using a percutaneous\n             CT-guided approach\n\n          -  Bone metastasis must be no greater than 8 cm\n\n          -  No tumor mass in contact with hollow viscera\n\n          -  No primary musculoskeletal malignancies, lymphoma, or leukemia\n\n          -  No spinal metastases that do not have an intact cortex between the mass and the\n             spinal canal and exiting nerve roots\n\n          -  No tumor involving weight-bearing long bone of lower extremity or impending fracture\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  21 and over\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Platelet count at least 70,000/mm^3\n\n          -  No uncontrolled coagulopathy or bleeding diathesis that cannot be corrected with\n             fresh frozen plasma and platelets\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        Cardiovascular:\n\n          -  No pacemaker\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  At least 14 days since prior chemotherapy for metastatic disease\n\n          -  No concurrent systemic chemotherapy for metastatic disease during and for 14 days\n             after study therapy\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  At least 30 days since prior radioisotopes for metastatic disease\n\n          -  No concurrent systemic radioisotopes for metastatic disease\n\n        Surgery:\n\n          -  No surgical stabilization of tumor site with metallic hardware\n\n        Other:\n\n          -  Prior aspirin, nonsteroidal anti-inflammatory medications, antiplatelet medications,\n             or warfarin must be discontinued for an appropriate period of time prior to study\n             based on the drug's half-life and known antiplatelet activity (e.g., 7 days for\n             aspirin and 24 hours for ibuprofen)\n\n          -  At least 24 hours since prior low molecular weight heparin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 9, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00026247", 
            "org_study_id": "CDR0000069012", 
            "secondary_id": "ACRIN-6661"
        }, 
        "intervention": [
            {
                "intervention_name": "pain therapy", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "radiofrequency ablation", 
                "intervention_type": "Procedure"
            }
        ], 
        "keyword": [
            "bone metastases", 
            "pain", 
            "unspecified adult solid tumor, protocol specific"
        ], 
        "lastchanged_date": "April 7, 2011", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/ACRIN-6661"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "Comprehensive Cancer Center at University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "UMASS Memorial Cancer Center - University Campus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Mallinckrodt Institute of Radiology at Washington University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Youngstown", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44512"
                    }, 
                    "name": "Radiology Consultants, Incorporated"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104-4283"
                    }, 
                    "name": "Abramson Cancer Center of the University of Pennsylvania"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107-5541"
                    }, 
                    "name": "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "02903"
                    }, 
                    "name": "Comprehensive Cancer Center at Rhode Island Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030-4009"
                    }, 
                    "name": "M.D. Anderson Cancer Center at University of Texas"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance", 
        "overall_official": {
            "affiliation": "Rhode Island Hospital", 
            "last_name": "Damian E. Dupuy, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "February 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Adverse events", 
            "safety_issue": "Yes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00026247"
        }, 
        "results_reference": {
            "PMID": "20041484", 
            "citation": "Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K, Lopez R, Safran H, DiPetrillo T. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010 Feb 15;116(4):989-97. doi: 10.1002/cncr.24837."
        }, 
        "secondary_outcome": [
            {
                "measure": "Pain intensity as assessed by the Memorial Pain Assessment Cards", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Pain relief", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Pain severity", 
                "safety_issue": "No"
            }, 
            {
                "measure": "Mood", 
                "safety_issue": "No"
            }
        ], 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "American College of Radiology Imaging Network", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2006"
    }, 
    "geocoordinates": {
        "Abramson Cancer Center of the University of Pennsylvania": "39.952 -75.164", 
        "Comprehensive Cancer Center at Rhode Island Hospital": "41.824 -71.413", 
        "Comprehensive Cancer Center at University of Alabama at Birmingham": "33.521 -86.802", 
        "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia": "39.952 -75.164", 
        "M.D. Anderson Cancer Center at University of Texas": "29.76 -95.369", 
        "Mallinckrodt Institute of Radiology at Washington University Medical Center": "38.627 -90.199", 
        "Radiology Consultants, Incorporated": "41.1 -80.65", 
        "UMASS Memorial Cancer Center - University Campus": "42.263 -71.802"
    }
}